Regional cerebral blood flow and cerebrovascular risk factors in the elderly population

Neurobiology of Aging

Volumn 19, Issue 1, 1998, Pages 57-64

  Claus, J J ^a   Breteler, M M B ^a   Hasan, D ^a   Krenning, E P ^a   Bots, M L ^a   Grobbee, D E ^a   Van Swieten, J C ^a   Van Harskamp, F ^a   Hofman, A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aging; Atherosclerosis; Regional cerebral blood flow; Risk factors for cerebrovascular disease

Indexed keywords

TECHNETIUM;

AGED; AGING; ARTICLE; ATHEROSCLEROSIS; BRAIN BLOOD FLOW; CEREBROVASCULAR DISEASE; FEMALE; FRONTAL CORTEX; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL CORTEX;

AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; ATROPHY; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; ECHOENCEPHALOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POPULATION; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031971869     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00004-9     Document Type: Article

References (58)

1. Ameriso S. F., Paganini-Hill A., Meiselman H. J., Fisher M. Correlates of middle cerebral artery blood velocity in the elderly. Stroke. 21:1990;1579-1583.
2. Aquilonius S. M., Eckernas S. A. A color atlas of the human brain. 1980;Raven Press, New York.
3. Arriagada P. V., Marzloff K., Hyman B. T. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology. 42:1992;1681-1688.
4. Bots M. L., Breslau P. J., Briët E., Bruijn A. M. d., Vliet H. D. D. M. v., Ouweland F. A. M. v., Jong P. T. V. M. d., Hofman A., Grobbee D. E. Cardiovascular determinants of carotid artery disease: The Rotterdam Elderly Study. Hypertension. 19:1992;717-720.
5. Bots M. L., Hofman A., Grobbee D. E. Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study. Arterioscler. Thromb. 14:1994;1885-1891.
6. Bots M. L., Mulder P. G. H., Hofman A., van Es G. A., Grobbee D. E. Reproducibility of carotid vessel wall thickness measurements. The Rotterdam Study. J. Clin. Epidemiol. 47:1994;921-930.
7. Bots M. L., van Swieten J. C., Breteler M. M. B., de Jong P. T. V. M., van Gijn J., Hofman A., Grobbee D. E. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet. 341:1993;1232-1237.
8. Breteler M. M. B., van Amerongen N. M., van Swieten J. C., Claus J. J., Grobbee D. E., van Gijn J., Hofman A., van Harskamp F. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke. 25:1994;1109-1115.
9. Breteler M. M. B., van Swieten J. C., Bots M. L., Grobbee D. E., Claus J. J., van den Hout J. H. W., van Harskamp F., Tanghe H. L. J., de Jong P. T. V. M., van Gijn J., Hofman A. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study The Rotterdam Study . Neurology. 44:1994;1246-1254.
10. Burns A., Tyrrell P. Association of age with regional cerebral oxygen utilization a positron emission tomography study . Age. Ageing. 21:1992;316-320.
11. Cavestri R., Radice L., Ferrarini F., Longhini M., Longhini E. Influence of erythrocyte aggregability and plasma fibrinogen concentration on CBF with aging. Acta. Neurologica. Scandinavica. 85:1992;292-298.
12. Chawluk J. B., Dann R., Alavi A., Hurtig H. I., Gur R. E., Resnick R., Zimmerman R. A., Reivich M. The effects of focal cerebral atrophy in positron emission tomographic studies of aging and dementia. Int. J. Radiat. Appl. Instrum. Part B Nucl. Med. Biol. 17:1990;797-804.
13. Claus J. J., Breteler M. M. B., Hasan D., Krenning E. P., Bots M. L., Grobbee D. E., van Swieten J. C., van Harskamp F., Hofman A. Vascular risk factors, atherosclerosis, cerebral white matter lesions and cerebral perfusion in a population-based study. Eur. J. Nucl. Med. 23:1996;675-682.
14. Claus J. J., Dubois E. A., Booij J., Habraken J., de Munck J. C., van Herk M., Verbeeten B. J., van Royen E. A. Demonstration of reduced muscarinic receptor binding in early Alzheimer's disease using [I-123]dexetimide SPET. Eur. J. Nucl. Med. 24:1997;602-608.
15. Claus J. J., van Harskamp F., Breteler M. M. B., Krenning E. P., de Koning I., vander Cammen T. J., Hofman A., Hasan D. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease a population-based study . Neurology. 44:1994;454-461.
16. Claus J. J., van Harskamp F., Breteler M. M. B., Krenning E. P., van der Cammen T. J., Hasan D. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease Effects of region of interest selection [see comments] . Eur. J. Nucl. Med. 21:1994;1044-1051.
17. Coull B. M., Beamer N., de Garmo P., Sexton G., Nordt F., Knox R., Seaman G. V. F. Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke. Stroke. 22:1991;162-168.
18. Dastur, D. K.; Lane, M. H.; Hansen, D. B.; Kety, S. S.; Butler, R. N.; Perlin, S.; Sokoloff, L. Effects of aging on cerebral circulation and metabolism in man. In: Birren, J. E.; Butler, R. N.; Greenhouse, S. W.; Sokoloff, L.; Yarrow, M. R., eds. Human aging - a biological and behavioral study. Bethesda, U.S. Department of Health, Education, and Welfare, National Institute of Mental Health, DHEW publication 986;1963:57-76.
19. Derix M. M., Hofstede A. B., Teunisse S., Hijdra A., Walstra G. J., Weinstein H. C., van Gool W. A. CAMDEX-N The Dutch version of the Cambridge Examination for Mental Disorders of the Elderly with automatic data processing . Tijdschr. Gerontol. Geriatr. 22:1991;143-150.
20. 133Xenon inhalation Accuracy in detection of ischemic cerebral regions and angiographic lesions . Wood J. H. Cerebral blood flow. Physiologic and clinical aspects. 1987;202-219 McGraw-Hill, New York.
21. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician . J. Psychiatr. Res. 12:1975;189-198.
22. Grotta J., Ackerman R., Correia J., Fallick G., Chang J. Whole blood viscosity parameters and cerebral blood flow. Stroke. 13:1982;296-301.
23. Gur R. C., Gur R. E., Obrist W. D., Skolnick B. E., Reivich M. Age and regional cerebral blood flow at rest and during cognitive activity. Arch. Gen. Psychiatry. 44:1987;617-621.
24. Hofman A., Grobbee D. E., de Jong P. T., van den Ouweland F. A. Determinants of disease and disability in the elderly The Rotterdam Elderly Study . Eur. J. Epidemiology. 7:1991;403-422.
25. Hofman A., Ott A., Breteler M. M. B., Bots M. L., Slooter A. J. C., van Harskamp F., van Duijn C. N., van Broeckhoven C., Grobbee D. E. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 349:1997;151-154.
26. Isaka Y., Okamoto M., Ashida K., Imaizumi M. Decreased cerebrovascular dilatory capacity in subjects with asymptomatic periventricular hyperintensities. Stroke. 25:1994;375-381.
27. Itoh M., Hatazawa J., Miyazawa H., Matsui H., Meguro K., Yanai K., Kubota K., Watanuki S., Ido T., Matsuzawa T. Stability of cerebral blood flow and oxygen metabolism during normal aging. Gerontology. 36:1990;43-48.
28. 1988 report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch. Int. Med. 148:1988;1023-1038.
29. Kannel W. B., Wolf P. A., Castelli W. P., D'Agostino R. B. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA. 258:1987;1183-1186.
30. Lartaud I., Bray-des-Boscs L., Chillon J. M., Atkinson J., Capdeville-Atkinson C. In vivo cerebrovascular reactivity in Wistar and Fisher 344 rat strains during aging. Am. J. Physiol. 264:1993;H851-H858.
31. Lartaud I., Makki T., Bray-des-Boscs L., Niederhoffer N., Atkinson J., Corman B., Capdeville-Atkinson C. Effect of chronic ANG I-converting enzyme inhibition on aging processes. IV. Cerebral blood flow regulation. Am. J. Physiol. 267:1994;R687-R694.
32. Leenders K. L., Perani D., Lammertsma A. A., Heather J. D., Buckingham P., Healy M. J. R., Gibbs J. M., Wise R. J. S., Hatazawa J., Herold S., Beaney R. P., Brooks D. J., Spinks T., Rhodes C., Frackowiak R. S. J., Jones T. Cerebral blood flow, blood volume and oxygen utilization normal values and effect of age . Brain. 113:1990;27-47.
33. Lindeboom J., ter Horst R., Hooyer C., Drinkgreve M., Jonker C. Some psychometric properties of the CAMCOG. Psychol. Med. 23:1993;213-219.
34. Marchal G., Rioux P., Petit-Taboué M. C., Sette G., Travère J. M., Le Poec C., Courtheoux P., Derlon J. M., Baron J. C. Regional cerebral oxygen consumption, blood flow, and blood volume in healthy human aging. Arch. Neurol. 49:1992;1013-1020.
35. Martin A. J., Friston K. J., Colebatch J. G., Frackowiak R. S. J. Decreases in regional cerebral blood flow with normal aging. J. Cereb. Blood Flow Metab. 11:1991;684-689.
36. McGeer P. L., Kamo H., Harrop R., et al. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. Can. Med. Assoc. J. 134:1986;597-607.
37. Meltzer C. C., Zubieta J. K., Brandt J., Tune L. E., Mayberg H. S., Frost J. J. Regional hypometabolism in Alzheimer's diseasse as measured by positron emission computed tomography after correction for effects of partial volume averaging. Neurology. 47:1996;454-461.
38. Meyer J. S., Terayama Y., Takashima S. Cerebral circulation in the elderly. Cerebrovasc. Brain Metab. Rev. 5:1993;122-146.
39. Miller B. L., Mena I., Daly J., Giombetti R. J., Goldberg M. A., Lesser I., Garrett K., Villanueva-Meyer J., Liu C. K. Temporo-parietal hypoperfusion with single-photon emission computed tomography in conditions other than Alzheimer's disease. Dementia. 1:1990;41-45.
40. Mirsen T. R., Lee D. H., Wong C. J., Diaz J. F., Fox A. J., Hachinski V. C., Merskey H. Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. Arch. Neurol. 48:1991;1015-1021.
41. Naritomi H., Meyer J. S., Sakai F., Yamagushi F., Shaw T. Effects of advancing age on regional cerebral blood flow. Studies in normal subjects and subjects with risk factors for atherothrombotic stroke. Arch. Neurol. 36:1979;410-416.
42. Pantano P., Baron J. C., Lebrun-Grandie P., Duquesnoy N., Bousser M. G., Comar D. Regional cerebral blood flow and oxygen consumption in human aging. Stroke. 15:1984;635-641.
43. Pignoli P., Tremoli E., Poli A., Oreste P., Paoletti R. Intimal plus medial thickness of the arterial wall A direct measurement with ultrasound imaging . Circulation. 74:1986;1399-1406.
44. Raichle M. E., Grubb R. L., Gado M. H., Eichling J. O., Ter-Pogossian M. M. Correlation between regional cerebral blood flow and oxidative metabolism. in vivo studies in man. Arch. Neurol. 33:1976;523-526.
45. Reivich M. Blood flow and metabolism couple in brain. Res. Pub. Assoc. Nerv. Ment. Dis. 53:1974;125-140.
46. Roth M., Huppert F. A., Tym E., Mountjoy C. O. CAMDEX, the Cambridge Examination for Mental Disorders of the Elderly. 1988;Cambridge University Press, Cambridge, England.
47. Scheibel A. B. The gerohistology of the aging human forebrain Some structuro-functional considerations . Enna S. J., Samorajski T., Beer B. Brain neurotransmitters and receptors in aging and age-related disorders. 1981;31-41 Raven Press, New York, NY.
48. Scheltens P., Pasquier F., Weerts J. G. E., Barkhof F., Leys D. Qualitative assessment of cerebral atrophy on MRI Inter- and intraobserver reproducibility in dementia and normal aging . Eur. Neurol. 37:1997;95-99.
49. Shaw T. G., Mortel K. F., Meyer J. S., Rogers R. L., Hardenberg J., Cutaia M. M. Cerebral blood flow changes in benign aging and cerebrovascular disease. Neurology. 34:1984;855-862.
50. Shuaib A. ALteration of blood pressure regulation and cerebrovascular disorders in the elderly. Cerebrovasc. Brain Metab. Rev. 4:1992;329-345.
51. Snowden D. A., Greiner L. H., Mortimer J. A., Riley K. P., Greiner P. A., Markesbery W. R. Brain infarction and the clinical expression of Alzheimer's disease. The Nun Study. JAMA. 277:1997;813-817.
52. Sparks D. L., Hunsaker J. C. III, Scheff S. W., Kryscio R. J., Henson J. L., Markesbery W. R. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol. Aging. 11:1990;601-607.
53. Sparks D. L., Scheff S. W., Liu H., Landers T., Danner F., Coyne C. M., Hunsaker J. C. III. Increased density of senile plaques (SP), but not fibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: Comparison to confirmed Alzheimer's disease patients. J. Neurol. Sci. 138:1996;97-104.
54. Strandgaard S., Paulson O. B. Cerebral autoregulation. Stroke. 15:1984;413-416.
55. Terry R. D., DeTeresa R., Hansen L. A. Neocortical cell counts in normal human adult aging. Ann. Neurol. 21:1987;530-539.
56. Waldemar G., Hasselbalch S. G., Andersen A. R., Delecluse F., Petersen P., Johnsen A., Paulson O. B. 99mTc-d,1-HMPAO and SPECT of the brain in normal aging. J. Cereb. Blood Flow Metab. 11:1991;508-521.
57. Yamagushi T., Kanno I., uemara K., Shishido F., Inugami A., Ogawa T., Murakami M., Suzuki K. Reduction in regional cerebral metabolic rate of oxygen during human aging. Stroke. 17:1986;1220-1228.
58. Yoshii F., Barker W. W., Change J. Y., Loewenstein D., Apicella A., Smith D., Boothe T., Ginsberg M. D., Pascal S., Duara R. Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brian atrophy, and cerebrovascular risk factors. J. Cereb. Blood Flow Metab. 8:1988;654-661.